CCIM, Institut für Entzündungsmedizin UKSH Lübeck

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Intervention With Tralokinumab in Patients With Moderate-to-severe Atopic Dermatitis With Genital Impact	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hypersensitivity, Immediate, Skin Diseases, Eczematous, Skin and Connective Tissue Diseases, atopic eczema, dermatitis, hereditary disease, hereditary skin disorder, immune system disorder, skin disorder	Recruiting	Not stated	2026-03-03		NCT07444801

Clinical trials